MOLECULAR PARTNERS AG -ADR (MOLN) Stock News

USA - NASDAQ:MOLN - US60853G1067 - ADR

4.22 USD

-0.06 (-1.4%)

Last: 11/14/2025, 8:06:09 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MOLN Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Molecular Partners

Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action

4 days ago - By: Molecular Partners

Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action

13 days ago - By: Molecular Partners

Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting

2 months ago - By: Benzinga

Looking Into Molecular Partners's Recent Short Interest

3 months ago - By: Benzinga - Mentions: PDD SNT NSSC SMTC ...

Earnings Scheduled For August 25, 2025

13 days ago - By: Molecular Partners

Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025

13 days ago - By: Molecular Partners

Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting

13 days ago - By: Molecular Partners

Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025

16 days ago - By: Molecular Partners

Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025

16 days ago - By: Molecular Partners

Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025

3 months ago - By: Molecular Partners

Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025

3 months ago - By: Molecular Partners

Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025

3 months ago - By: Molecular Partners

Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics

3 months ago - By: Molecular Partners

Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics

5 months ago - By: Molecular Partners

Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025

5 months ago - By: Molecular Partners

Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025

5 months ago - By: Molecular Partners

Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025

5 months ago - By: Molecular Partners

Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025

5 months ago - By: Molecular Partners

Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway

5 months ago - By: Molecular Partners

Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway

6 months ago - By: Molecular Partners

Molecular Partners to Present at Upcoming Investor Conferences

6 months ago - By: Molecular Partners

Molecular Partners to Present at Upcoming Investor Conferences

6 months ago - By: Molecular Partners

Molecular Partners Reports Financial Results and Highlights from Q1 2025

6 months ago - By: Molecular Partners

Molecular Partners Reports Financial Results and Highlights from Q1 2025

7 months ago - By: Molecular Partners

Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025

7 months ago - By: Molecular Partners

Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025

7 months ago - By: Molecular Partners

Molecular Partners Announces all Board Proposals Approved at Annual General Meeting

7 months ago - By: Molecular Partners

Molecular Partners Announces all Board Proposals Approved at Annual General Meeting

8 months ago - By: Molecular Partners

Molecular Partners to hold three poster presentations at AACR 2025

8 months ago - By: Molecular Partners

Molecular Partners to hold three poster presentations at AACR 2025